Home | Regional | North America | United States | Government | Executive Branch | Departments | Health and Human Services | Food and Drug Administration | Center for Biologics Evaluation and Research

http://www.fda.gov/cber/allergenics.htm

Regulates allergenic products. Site links to Advisory Committee meeting schedule and allergenics policy guides.

http://www.fda.gov/cber/blood.htm

The FDA is responsible for ensuring the safety of our nation's blood supply. The CBER regulates the collection of blood and blood components used for transfusion or for the manufacture of pharmaceuticals derived from blood and blood components, such as clotting factors, and establishes standards for the products themselves.

Center for Biologics Evaluation & Research (CB

http://www.fda.gov/cber/

Protects and enhances the public health through regulation of biological products including blood, vaccines, therapeutics and related drugs and devices according to statutory authorities

Devices

http://www.fda.gov/cber/devices.htm

The CBER regulates the medical devices involved in the collection, processing, testing, manufacture and administration of licensed blood, blood components and cellular products. CBER also regulates all HIV test kits.

Electronic Freedom of Information Act Reading Room

http://www.fda.gov/cber/reading.htm

Provides access to all the documents posted on the CBER website. These documents are ones frequently requested by the public through the Freedom of Information Act.

Licensed Product Information

http://www.fda.gov/cber/efoi/approve.htm

Alphabetical list by the proper name of the product. Links to the approval letter, label and review documents files for each product.

Therapeutics

http://www.fda.gov/cber/therapies.htm

The Center regulates a variety of biological therapeutic products, as diverse as blood and blood components; antitoxins; proteins generated by hybridoma or recombinant DNA technology; products that consist of manipulated, cultured, or expanded human cells; vaccines directed against non-infectious disease targets; and gene transfer products.

Tissue

http://www.fda.gov/cber/tiss.htm

The CBER currently regulates human tissue intended for transplantation. Examples of such tissues are bone, skin, corneas, ligament and tendon.

Vaccines

http://www.fda.gov/cber/vaccines.htm

The Center regulates vaccine products. Vaccines undergo a rigorous review of laboratory and clinical data to ensure the safety, efficacy, purity and potency of these products. Major sections are Flu Vaccine, Thimerosal, Anthrax, and Bovine Spongiform Encephalopathy, ("mad cow disease.")